FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2012/02/002464 [Registered on: 28/02/2012] Trial Registered Retrospectively
Last Modified On: 28/11/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study
Modification(s)  
Homeopathy in Controlling Essential Hypertension 
Scientific Title of Study   Exploring the Efficacy of Homoeopathy in Controlling Essential Hypertension: A Prospective Single-blind Randomized Controlled Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
1343/MBHMCH/CH/H/01/11  Protocol Number 
U1111-1128-2447  UTN 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Subhranil Saha 
Designation  House Staff 
Affiliation  Mahesh Bhattacharyya Homeopathic Medical College and Hospital 
Address  93/2/1 Shibpur Road PO and PS Shibpur Howrah
Drainage Canal Road Doomurjala Howrah West Bengal Pin 711104
Haora
WEST BENGAL
711102
India 
Phone  09836187425  
Fax    
Email  drsubhranilsaha@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Subhranil Saha 
Designation  House Staff 
Affiliation  Mahesh Bhattacharyya Homeopathic Medical College and Hospital 
Address  93/2/1 Shibpur Road PO and PS Shibpur Howrah
Drainage Canal Road Doomurjala Howrah West Bengal Pin 711104
Haora
WEST BENGAL
711102
India 
Phone  09836187425  
Fax    
Email  drsubhranilsaha@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Subhranil Saha 
Designation  House Staff 
Affiliation  Mahesh Bhattacharyya Homeopathic Medical College and Hospital 
Address  93/2/1 Shibpur Road PO and PS Shibpur Howrah
Drainage Canal Road Doomurjala Howrah West Bengal Pin 711104
Haora
WEST BENGAL
711102
India 
Phone  09836187425  
Fax    
Email  drsubhranilsaha@hotmail.com  
 
Source of Monetary or Material Support  
Mahesh Bhattacharyya Homeopathic Medical College and Hospital 
 
Primary Sponsor  
Name  Mahesh Bhattacharyya Homeopathic Medical College and Hospital 
Address  Drainage Canal Road Doomurjala Howrah West Bengal Pin 711104 India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Subhranil Saha  OPD and IPD of Mahesh Bhattacharyya Homeopathic Medical College & Hospital  Drainage Canal Road Doomurjala
Haora
WEST BENGAL 
09836187425

drsubhranilsaha@hotmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of Mahesh Bhattacharyya Homoeopathic Medical College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I10||Essential (primary) hypertension, Essential Hypertension,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homeopathic medicines  Intervention - 5 ml dose of Homeopathic medicine in 6/30/200/1M/10M/50M or 0/1 - 0/40 potency OD/BDS/TDS/QDS or as appropriate for 6 months.  
Comparator Agent  Placebo  5 ml dose of rectified spirit in distilled water, identical in appearance of Homeopathic medicine OD for 6 months.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1. Age between 18 years and 75 years
2. Both sexes
3. Suffering from essential/primary hypertension for at least 6 months 
 
ExclusionCriteria 
Details  1. Any continued anti-hypertensive therapy for at least 6 months
2. Malignant Hypertension with grave signs and symptoms as detected clinically
3. Patients suffering from isolated systolic hypertension
4. Patients not strictly conforming to the criteria given by JNC-7; variation of ±10 mm Hg in SBP/DBP considerable
5. Presence of severe concomitant disease(s)
6. Pregnancy, breast feeding and likelihood of pregnancy 
 
Method of Generating Random Sequence
Modification(s)  
Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment
Modification(s)  
Pharmacy-controlled Randomization 
Blinding/Masking
Modification(s)  
Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Reduction in systolic blood pressure (SBP)
2. Reduction in diastolic blood pressure (DBP) 
6 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. Clinical improvement in symptom scores
2. Halt of the disease progress and complications
3. Prevention of relapse
3. Incidence of adverse events if any 
6 months 
 
Target Sample Size   Total Sample Size="132"
Sample Size from India="132" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/04/2011 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Other (Terminated) 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
A single-center, prospective, participant blind, randomized, placebo-controlled, parallel group, interventional clinical trial was planned to enroll 132 participants (subjects 64, control 68) suffering from essential hypertension from April, 2011 at Mahesh Bhattacharyya Homeopathic Medical College and Hospital. The aim of this trial was to evaluate the efficacy and/or safety of homeopathic medicines in reducing systolic and/or diastolic blood pressure measured at timeline of 6 months. Inclusion criteria include age between 18 and 75 years and both sexes and more than 6 months history of suffering from essential hypertension. Exclusion criteria include any continued anti-hypertensive therapy for at least 6 months, malignant Hypertension with grave signs and symptoms as detected clinically, patients suffering from isolated systolic hypertension. The protocol needed amendments and the study was terminated prematurely.
 
Close